Non Hodgkin Lymphoma Clinical Trial

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Summary

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

View Full Description

Full Description

Patients who participate will be asked to complete detailed family and medical history questionnaires initially, with a follow-up questionnaire every year.
Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of which can be done by mail.
Patients will be asked to consent to the release of their lymphoma tissue block for the purposes of the study.
Patients will be given letters of invitation for their affected relatives to invite them to participate.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child) with a lymphoproliferative disorder; or families in which the individual has a lymphoproliferative disorder, and an unusual clustering of frequent or premature solid tumors is also observed.
Family members of the individual, either affected or unaffected with lymphoma, who are contacted by the individual and agree to participate in the study.
Deceased family members may be included in the study. Public records such as death certificates may be used to confirm the history. Consent for medical records or tissue blocks will be obtained from the deceased family member's next of kin. The hierarchy of relatives defined as next of kin is spouse, offspring, parents and siblings. Archived tissue samples may be used for genetic research.
Age > 18 years

Exclusion Criteria:

Subjects without a family history of lymphoma

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

1500

Study ID:

NCT00131014

Recruitment Status:

Recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana-Farber Cancer Institute
Boston Massachusetts, 02115, United States More Info
Jennifer R. Brown, MD, PhD
Contact
617-632-6692
[email protected]
Jennifer R. Brown, MD, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

1500

Study ID:

NCT00131014

Recruitment Status:

Recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.